University of Florida
Gainesville, Florida, 32611, United States
NCT Number: NCT01709825
The purpose of this study is to determine if daily consumption of a probiotic in the period before, during and after academic exams will help maintain digestive and immune health and quality of life of undergraduate students.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Gainesville, Florida, 32611, United States
A randomized, double-blinded, placebo-controlled trial will be used. Healthy full-time undergraduate students will be recruited from the University of Florida via flyers, emails, announcements, etc. Informed consent will be obtained and the inclusion/exclusion criteria will be reviewed to determine whether a participant qualifies for the study. All participants will be consented for the main six-week intervention and a subgroup (n=50/group) of these students will be consented to provide two stool samples.
Participants will provide saliva and stool samples (for the sub-group)during the pre-baseline week and during the week of final exams at approximately week 4. At the randomization visit, height, weight and age will be obtained. Participants will be stratified based on body mass index and randomized via sealed envelopes to one of four groups: Lactobacillus helveticus, Bifidobacterium longum ssp. Infantis, Bifidobacterium bifidum or the placebo (n=145/group). Participants will take the study provided capsule of probiotic or placebo daily for 6 weeks. Participants will receive daily questionnaires via email throughout the prebaseline week and the 6-week intervention. Daily questionnaires will ask about intake of the supplement, cold symptoms, and general health (i.e., new medications, doctor visits). Throughout the study, participants will also be asked to complete weekly questionnaires (inquiring about gastrointestinal symptoms and physical activity) and Quality of Life Questionnaires (administered during pre-baseline, final exam week and week 6 of the study).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
To participate in the study you must:
Exclusion criteria
To participate in the study you must NOT:
Bifidobacterium bifidum R0071 will be taken as a capsule once daily for 6 weeks.
Other names: Bifidobacterium bifidum, Supplement A
Sugar Pill (Sucrose) will be taken as a capsule once daily for 6 weeks.
Other names: Sucrose
Lactobacillus helveticus R0052 will be taken as a capsule once daily for 6 weeks.
Other names: Lactobacillus helveticus, Supplement B
Bifidobacterium longum ss. Infantis R0033 (Supplement C) will be taken as a capsule once daily for 6 weeks.
Other names: Bifidobacterium longum ss. Infantis R0033, Supplement C
Time frame: over 6 weeks
The intensity of cold/flu symptoms (running/congested nose, stiffness or chills, headache, cough, fatigue, fever, sore throat, achiness, and ear discomfort)will be scored as 0 (not experiencing) to 3 (severe). The symptom intensity from the 9 cold/flu symptoms will be summed to obtain a symptom intensity score. A symptom intensity score of >6 will be designated as a day of cold. The mean proportion of days without a cold/flu will be compared between each probiotic and the placebo.
Time frame: Change in microbiota from pre-baseline to on average week 4
Time frame: Daily for 7 weeks
Time frame: Measured at pre-baseline and on average week 4
University of Florida
Other
The Effect of Probiotics on Immune Function, and Digestive Health in Academically-stressed University Students: A Randomized, Double-blinded, Placebo-controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04326309
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial DetailsNCT01302561
Common Cold, Healthy
Gainesville, Florida, United States
View Trial DetailsNCT01137760
Common Cold, Healthy
Gainesville, Florida, United States
View Trial DetailsNCT04381689
Healthy, Infections
Ansan-si, Gyeonnggi-do, South Korea
View Trial Details